| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00058 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |